查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421669

癌症活检市场、份额、规模、趋势、行业分析报告：按产品类型、应用、地区、细分市场预测，2024-2032 年

Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球癌症活检市场规模预计将达到 920.9 亿美元。 该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

活检是一种从身体任何部位取出组织以检测疾病的医疗程序。 使用多种方法，包括针头收集和手术收集。 MRI 和 CT 扫描等影像学检查可以识别异常情况，但无法区分癌细胞和非癌细胞。 因此，活检对于确认恶性肿瘤的诊断至关重要，并涉及详细的细胞分析。

体液切片的进步正在显着影响癌症活检市场的成长。 这项创新技术分析血液中的遗传物质，以便可以采用非侵入性方法来检测和监测特定的癌症类型。

活检提供了对不同癌症类型的生物学特性的重要见解。 这些资讯可用于确定潜在的药物标靶和规划临床试验以评估新疗法。 活检也用于监测治疗反应并确定抗药性机制，有助于开发更有效的药物和联合疗法。

癌症切片市场面临许多挑战。 先进的活检技术和分子分析技术在资源有限的地区并不容易取得。 此外，解释复杂的基因组数据需要专业知识，这凸显了肿瘤学继续教育和培训的必要性。 侵入性活检程序可能会给患者带来不适，导致患者不愿意接受该程序。 此外，对于某些个人和卫生系统来说，活检程序和相关技术的成本可能太高。 克服这些挑战对于确保平等获得优质活检服务并最大限度地提高癌症诊断和治疗的有效性至关重要。

癌症切片市场报告亮点

  • 由于广泛使用，液体活检领域预计在预测期内将以最高复合年增长率增长。
  • 套件和耗材细分市场在 2022 年占据最大的市场份额，这主要是由于成本效益和高性能。
  • 乳癌细分市场在 2022 年占据了很大的市场收入份额，这主要是由于其高盛行率。
  • 到 2022 年，北美地区将占据大部分市场；

目录

第1章简介

第 2 章执行摘要

第3章研究方法

第 4 章全球癌症切片市场洞察

  • 癌症切片市场－应用概况
  • 癌症切片市场动态
    • 推动者和机会
      • 癌症患者的增加预计将刺激产品需求
      • 分子诊断方法的进展
    • 抑制因素和挑战
      • 与癌症切片相关的高成本
  • PESTEL 分析
  • 癌症切片市场的应用趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球癌症切片市场（按类型）

  • 主要调查结果
  • 简介
  • 体液切片
  • 组织切片
  • 其他

第 6 章全球癌症切片市场（依产品类型）

  • 主要调查结果
  • 简介
  • 套件和消耗品
  • 设备
  • 服务

第 7 章全球癌症切片市场（按应用）

  • 主要调查结果
  • 简介
  • 乳癌
  • 子宫颈癌
  • 肺癌
  • 大肠直肠癌
  • 其他

第 8 章全球癌症切片市场（按地区）

  • 主要调查结果
  • 简介
    • 2019-2032 年癌症切片市场评估（按地区）
  • 癌症切片市场 - 北美
    • 北美：2019-2032 年癌症切片市场（按类型）
    • 北美：癌症活检市场，按应用划分，2019-2032 年
    • 北美：癌症切片市场，依产品类型，2019-2032 年
    • 癌症切片市场－美国
    • 癌症切片市场 - 加拿大
  • 癌症切片市场 - 欧洲
    • 欧洲：2019-2032 年癌症切片市场（按类型）
    • 欧洲：癌症活检市场，按应用划分，2019-2032 年
    • 欧洲：癌症切片市场（按产品类型），2019-2032 年
    • 癌症切片市场－英国
    • 癌症切片市场 - 法国
    • 癌症切片市场 - 德国
    • 癌症切片市场 - 义大利
    • 癌症切片市场 - 西班牙
    • 癌症切片市场 - 荷兰
    • 癌症切片市场 - 俄罗斯
  • 癌症切片市场 - 亚太地区
    • 亚太地区：癌症切片市场（按类型），2019-2032 年
    • 亚太地区：癌症活检市场，按应用划分，2019-2032 年
    • 亚太地区：癌症切片市场（依产品类型），2019-2032 年
    • 中国癌症切片市场
    • 癌症切片市场 - 印度
    • 癌症切片市场 - 马来西亚
    • 癌症切片市场 - 日本
    • 印尼癌症切片市场
    • 韩国癌症切片市场
  • 癌症切片市场 - 中东和非洲
    • 中东和非洲：癌症活检市场（按类型），2019-2032 年
    • 中东和非洲：癌症活检市场，按应用划分，2019-2032 年
    • 中东和非洲：癌症活检市场（按产品类型），2019-2032 年
    • 癌症切片市场 - 沙乌地阿拉伯
    • 癌症切片市场 - 阿拉伯联合大公国
    • 癌症切片市场 - 以色列
    • 癌症切片市场 - 南非
  • 癌症切片市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年癌症切片市场（按类型）
    • 拉丁美洲：癌症活检市场，按应用划分，2019-2032 年
    • 拉丁美洲：癌症活检市场，按产品类型划分，2019-2032 年
    • 癌症切片市场 - 墨西哥
    • 癌症切片市场 - 巴西
    • 癌症切片市场 - 阿根廷

第9章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 伙伴关係/协作/协议/揭露

第10章公司简介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Illumina, Inc.
  • Koninklijke Philips N.V.
  • Myriad Genetics, Inc.
  • NeoGenomics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Veracyte, Inc.
Product Code: PM4004

The global cancer biopsy market size is expected to reach USD 92.09 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A biopsy is a medical procedure that involves extracting tissue from any part of the body to detect diseases. Different methods, including needle-based or surgical extraction, are used. Imaging tests such as MRIs and CT scans can identify abnormalities, but they cannot differentiate between cancerous and non-cancerous cells. Therefore, biopsies are essential to confirm malignancy diagnoses and involve detailed cellular analysis.

Advancements in liquid biopsies have significantly influenced the growth of the cancer biopsy market. This innovative technique analyzes genetic material in the bloodstream, making it possible to detect and monitor specific cancer types in a non-invasive approach.

Biopsies offer crucial insights into the biology of different cancer types. This information is instrumental in identifying potential drug targets and designing clinical trials to evaluate new therapies. Biopsies are also used to monitor treatment response and identify mechanisms of resistance, contributing to the development of more effective drugs and combination therapies.

The cancer biopsy market is facing numerous challenges. Advanced biopsy techniques and molecular profiling technologies are not readily available in areas with limited resources. Additionally, interpreting complex genomic data requires specialized expertise, which highlights the need for ongoing education and training in oncology. Invasive biopsy procedures can cause discomfort to patients, leading to reluctance to undergo the process. Moreover, the cost of biopsy procedures and related technologies can be too high for some individuals and healthcare systems. It is vital to overcome these challenges to ensure equal access to high-quality biopsy services and to maximize their impact on cancer diagnosis and treatment.

Cancer Biopsy Market Report Highlights

  • The liquid biopsy segment is expected to grow at the highest CAGR during the projected period on account of wide usage
  • The kits and consumables segment accounted for the largest market share in 2022, which is mainly driven by cost-effectiveness and higher performance.
  • The breast cancer segment held a significant market revenue share in 2022, mainly due to its high prevalence rate
  • North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare system
  • The global key market players include: Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc

Polaris Market Research has segmented the cancer biopsy market report based on type, product type, application, and region:

Cancer Biopsy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Liquid, Biopsy
  • Tissue Biopsy
  • Others

Cancer Biopsy, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Kits and Consumables
  • Instruments
  • Services

Cancer Biopsy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Breast Cancer
  • Cervical Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Others

Cancer Biopsy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer Biopsy Market Insights

  • 4.1. Cancer Biopsy Market - Application Snapshot
  • 4.2. Cancer Biopsy Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in cancer cases is projected to spur the product demand
      • 4.2.1.2. Advancements in molecular diagnostics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High costs associated with cancer biopsy tests
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Cancer Biopsy Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer Biopsy Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Liquid, Biopsy
    • 5.3.1. Global Cancer Biopsy Market, by Liquid, Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.4. Tissue Biopsy
    • 5.4.1. Global Cancer Biopsy Market, by Tissue Biopsy, by Region, 2019-2032 (USD Billion)
  • 5.5. Others
    • 5.5.1. Global Cancer Biopsy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Biopsy Market, by Product Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 6.3. Kits and Consumables
    • 6.3.1. Global Cancer Biopsy Market, by Kits and Consumables, by Region, 2019-2032 (USD Billion)
  • 6.4. Instruments
    • 6.4.1. Global Cancer Biopsy Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.5. Services
    • 6.5.1. Global Cancer Biopsy Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Cancer Biopsy Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 7.3. Breast Cancer
    • 7.3.1. Global Cancer Biopsy Market, by Breast Cancer, By Region, 2019-2032 (USD Billion)
  • 7.4. Cervical Cancer
    • 7.4.1. Global Cancer Biopsy Market, by Cervical Cancer, By Region, 2019-2032 (USD Billion)
  • 7.5. Lung Cancer
    • 7.5.1. Global Cancer Biopsy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
  • 7.6. Colorectal Cancer
    • 7.6.1. Global Cancer Biopsy Market, by Colorectal Cancer, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Cancer Biopsy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Cancer Biopsy Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Cancer Biopsy Market - North America
    • 8.3.1. North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.3. North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.4. Cancer Biopsy Market - U.S.
      • 8.3.4.1. U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.3.5. Cancer Biopsy Market - Canada
      • 8.3.5.1. Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4. Cancer Biopsy Market - Europe
    • 8.4.1. Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.4. Cancer Biopsy Market - UK
      • 8.4.4.1. UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.5. Cancer Biopsy Market - France
      • 8.4.5.1. France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.6. Cancer Biopsy Market - Germany
      • 8.4.6.1. Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.7. Cancer Biopsy Market - Italy
      • 8.4.7.1. Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.8. Cancer Biopsy Market - Spain
      • 8.4.8.1. Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.9. Cancer Biopsy Market - Netherlands
      • 8.4.9.1. Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.4.10. Cancer Biopsy Market - Russia
      • 8.4.10.1. Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5. Cancer Biopsy Market - Asia Pacific
    • 8.5.1. Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.4. Cancer Biopsy Market - China
      • 8.5.4.1. China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.5. Cancer Biopsy Market - India
      • 8.5.5.1. India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.6. Cancer Biopsy Market - Malaysia
      • 8.5.6.1. Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.7. Cancer Biopsy Market - Japan
      • 8.5.7.1. Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.8. Cancer Biopsy Market - Indonesia
      • 8.5.8.1. Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.5.9. Cancer Biopsy Market - South Korea
      • 8.5.9.1. South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6. Cancer Biopsy Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.4. Cancer Biopsy Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.5. Cancer Biopsy Market - UAE
      • 8.6.5.1. UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.6. Cancer Biopsy Market - Israel
      • 8.6.6.1. Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.6.7. Cancer Biopsy Market - South Africa
      • 8.6.7.1. South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7. Cancer Biopsy Market - Latin America
    • 8.7.1. Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.4. Cancer Biopsy Market - Mexico
      • 8.7.4.1. Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.5. Cancer Biopsy Market - Brazil
      • 8.7.5.1. Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
    • 8.7.6. Cancer Biopsy Market - Argentina
      • 8.7.6.1. Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bio-Rad Laboratories, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. F. Hoffmann-La Roche Ltd.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Hologic, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Illumina, Inc.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Koninklijke Philips N.V.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Myriad Genetics, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. NeoGenomics, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. QIAGEN N.V.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Siemens Healthineers AG
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Sysmex Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Thermo Fisher Scientific Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Veracyte, Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 2 Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 3 Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 4 Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 6 North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 7 North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 8 U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 10 U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 11 Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 13 Canada: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 14 Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 16 Europe: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 17 UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 18 UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 19 UK: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 20 France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 21 France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 22 France: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 23 Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 25 Germany: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 26 Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 28 Italy: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 29 Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 31 Spain: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 35 Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 37 Russia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 41 China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 42 China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 43 China: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 44 India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 45 India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 46 India: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 50 Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 52 Japan: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 56 South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 58 South Korea: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 65 UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 67 UAE: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 68 Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 70 Israel: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 71 South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 73 South Africa: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 74 Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 76 Latin America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 77 Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 79 Mexico: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 80 Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 82 Brazil: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • Table 83 Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • Table 85 Argentina: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Cancer Biopsy Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product Type
  • Figure 7. Global Cancer Biopsy Market, by Product Type, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Type
  • Figure 9. Global Cancer Biopsy Market, by Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Application
  • Figure 11. Global Cancer Biopsy Market, by Application, 2022 & 2032 (USD Billion)
  • Figure 12. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Cancer Biopsy Market